ALA 6.06% 17.5¢ arovella therapeutics limited

just around the corner, page-128

  1. 8,830 Posts.
    lightbulb Created with Sketch. 1711
    The problem here is like always positive posters resort to name calling just because they have a different outlook on things

    And they keep repeating the same things over and over again but dont like it when those who disagree with them do the same thing.

    But the true facts are that this management have not delivered on their own timelines, business goals etc go back over the announcements they put out from end of 2013 to start of 2016 and you will see what I mean.

    Read some of the posts also put out in that time and see where that leads you.

    The only product that they have gotten any money for has been Zolpimist, which has been on sale in the USA, and yes relaunched in USA so IMO this is the only reason they have gotten any interest in this product.

    Twice unsuccessful in gaining funding for Artimist, so interest for anyone else it seems, failed trails, failed due diligence, nothing on the so called bunking bunnies, no movement on SUD 002, 003 so if they are working so hard where are the results.

    If they are working as hard as you say and still can not get deals done then its time to get out and give someone else a go
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.010(6.06%)
Mkt cap ! $183.9M
Open High Low Value Volume
17.0¢ 18.5¢ 16.5¢ $460.1K 2.614M

Buyers (Bids)

No. Vol. Price($)
5 255235 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 189078 5
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.